T2 Biosystems(us:TTOO)
0.3519
+0.54%
Updated on 2024-12-23
Open:0.3538
Close:0.3519
High:0.3590
Low:0.3400
Pre Close:0.3500
Volume:561378.00
Amount:198885.19
Turnover:2.67%
Shares:21.04M
MarketCap:7.41M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 1 | 310 | 0.00% | 0 | 0 | 0 |
| 2024-03-31 | 22 | 173270 | 3.14% | 2 | 5 | 8 |
| 2023-12-31 | 42 | 218288 | 5.38% | 4 | 5 | 29 |
| 2023-09-30 | 47 | 376514 | 0.10% | 20 | 12 | 12 |
| 2023-06-30 | 40 | 6417754 | 2.65% | 7 | 10 | 12 |
| 2023-03-31 | 40 | 3897087 | 19.13% | 13 | 4 | 14 |
| 2022-12-31 | 63 | 514362 | 6.67% | 5 | 8 | 48 |
| 2022-09-30 | 67 | 493686 | 0.14% | 6 | 13 | 17 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 45695 | 0.83% | 0 | |
| 2024-03-31 | Susquehanna International Group, Llp | 41166 | 0.75% | -13838 | -25.16% |
| 2024-03-31 | Blackrock Inc. | 36961 | 0.67% | 0 | |
| 2024-03-31 | Geode Capital Management, Llc | 27840 | 0.51% | 3786 | 15.74% |
| 2024-03-31 | Virtu Financial Llc | 13096 | 0.24% | 3018 | 29.95% |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 2858 | 0.05% | 819 | 40.17% |
| 2024-03-31 | Group One Trading, L.P. | 2046 | 0.04% | -1238 | -37.70% |
| 2024-03-31 | Ubs Group Ag | 1750 | 0.03% | 1750 | |
| 2024-03-31 | Royal Bank Of Canada | 1384 | 0.03% | 82 | 6.30% |
| 2024-03-31 | Cwm, Llc | 310 | 0.01% | 0 |
About
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Address:101 Hartwell Avenue
Website:http://www.t2biosystems.com
Market Movers